HCA HEALTHCARE, INC.

(HCA)
  Report
Delayed Nyse  -  05/13 04:00:02 pm EDT
214.92 USD   +0.52%
04:13aKeith Zimmerman Appointed President of HCA Healthcare's MidAmerica Division; HCA Healthcare Veteran Mel Lagarde to Retire
AQ
05/13Keith Zimmerman Appointed President of HCA Healthcare's MidAmerica Division
BU
05/13HCA Healthcare, Inc. Appoints Keith Zimmerman as President of the Company’s Kansas City-Based Midamerica Division
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Hca Healthcare

01/07/2022 | 06:10am EDT


ę MT Newswires 2022
All news about HCA HEALTHCARE, INC.
04:13aKeith Zimmerman Appointed President of HCA Healthcare's MidAmerica Division; HCA Health..
AQ
05/13Keith Zimmerman Appointed President of HCA Healthcare's MidAmerica Division
BU
05/13HCA Healthcare, Inc. Appoints Keith Zimmerman as President of the Company’s Kansas..
CI
05/11TRANSCRIPT : HCA Healthcare, Inc. Presents at Bank of America 2022 Healthcare Conference, ..
CI
05/05INSIDER BUY : HCA Healthcare
MT
05/04INSIDER BUY : HCA Healthcare
MT
05/03HCA HEALTHCARE, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIA..
AQ
05/03INSIDER BUY : HCA Healthcare
MT
05/03Mizuho Securities Adjusts HCA Healthcare's Price Target to $260 From $290, Reiterates B..
MT
05/02HCA Healthcare, Inc. to Present at May Healthcare Conferences
BU
More news
Analyst Recommendations on HCA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2022 60 745 M - -
Net income 2022 5 177 M - -
Net Debt 2022 35 097 M - -
P/E ratio 2022 12,5x
Yield 2022 1,03%
Capitalization 63 506 M 63 506 M -
EV / Sales 2022 1,62x
EV / Sales 2023 1,53x
Nbr of Employees 244 000
Free-Float 75,7%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 214,92 $
Average target price 251,91 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
P. Martin Paslick VP-Information Technology & Services
Kathleen M. Whalen Senior VP, Chief Ethics & Compliance Officer